Asia‐inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler
Abstract With the International Conference on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E17 guidelines in effect from 2018, the design of Asia‐inclusive multiregional clinical trials (MRCTs) has been streamlined, thereby enabling efficient simultaneous global de...
Saved in:
Main Authors: | Hong Lu (Author), Lena Klopp‐Schulze (Author), Jatinder Kaur Mukker (Author), Dandan Li (Author), Yoshihiro Kuroki (Author), Jayaprakasam Bolleddula (Author), Nadia Terranova (Author), Kosalaram Goteti (Author), Wei Gao (Author), Rainer Strotmann (Author), Jennifer Dong (Author), Karthik Venkatakrishnan (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug-drug interaction studies
by: Jayaprakasam Bolleddula, et al.
Published: (2022) -
Model‐based meta‐analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus
by: Kosalaram Goteti, et al.
Published: (2024) -
Explainable machine learning prediction of edema adverse events in patients treated with tepotinib
by: Federico Amato, et al.
Published: (2024) -
Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model‐based dose-toxicity models
by: Kristyn Pantoja, et al.
Published: (2022) -
Model‐informed assessment of ethnic sensitivity and dosage justification for Asian populations in the global clinical development and use of cladribine tablets
by: Alain Munafo, et al.
Published: (2022)